Answers are grounded in this paper and cite their sources.
The search for an HIV cure involves navigating an NP-hard combinatorial space of molecular interactions, immune dynamics, and viral evolution. Traditional optimization approaches suffer from error accumulation as they scale, leading to suboptimal therapeutic strategies. Here we present a novel Five-Phase Computational Framework that combines hierarchical renormalization with trap genotype convergence, mathematically guaranteeing error convergence and complete viral elimination. We formalize two theorems: (1) a convergence theorem showing that error stabilizes at a theoretical floor ε∞ = β·εlocal/(1-α) when renormalization is applied at each hierarchical level, and (2) a trap genotype convergence theorem demonstrating that evolutionary pressure can force viral populations toward a susceptible genotype through documented hypersusceptibility mechanisms. Through iterative computational validation across five system versions (v1 to v4.1) and stress testing against extreme pan-resistance scenarios using real-world mutation data from the Stanford HIV Drug Resistance Database, we demonstrate that our framework achieves complete viral elimination (0.00 copies/mL) within 0.2 days in silico, and reduces viral load from 100,000 to 40 copies/mL in worst-case pan-resistant profiles. This framework provides a computationally tractable, biologically interpretable pathway for in silico clinical trials and adaptive therapy design in complex biological systems.
No takes yet. Share an insight, caveat, or question.
Mauro Herrera Baez (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: